CASI Pharmaceuticals (CASIF) Net Income - Minority (2022)
CASI Pharmaceuticals (CASIF) reported Net Income - Minority of -$33.9 million for Q4 2022, little changed quarter-over-quarter from -$33.9 million in Q3 2022.
CASI Pharmaceuticals (CASIF) Net Income - Minority (2022) Analysis & Trends
CASI Pharmaceuticals has reported Net Income - Minority for 1 years, with the latest figure at -$33.9 million in Q4 2022.
- For the quarter ending Q4 2022, Net Income - Minority changed N/A year-over-year to -$33.9 million; the trailing twelve-month figure through Dec 2022 stood at -$33.9 million (changed N/A YoY), and the FY2022 full-year result was -$33.9 million, changed N/A from the prior year.
- Net Income - Minority for Q4 2022 stood at -$33.9 million, roughly flat from -$33.9 million in the prior quarter.
- The five-year high for Net Income - Minority was -$33.9 million in Q3 2022, with the low at -$33.9 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | CASI Pharmaceuticals | - | - | 3.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -33.90 Mn |
| Sep 30, 2022 | -33.90 Mn |